{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T08:15:52Z","timestamp":1762157752072,"version":"3.41.0"},"reference-count":38,"publisher":"Pharmaceutical Society of Japan","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2017]]},"DOI":"10.1248\/bpb.b16-00370","type":"journal-article","created":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T22:08:35Z","timestamp":1497391715000},"page":"1344-1351","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of CYP2D6 Protein Expression and Activity in the Small Intestine to Determine Its Metabolic Capability in the Japanese Population"],"prefix":"10.1248","volume":"40","author":[{"given":"Momoko","family":"Kawakami","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology, Showa University School of Medicine"},{"name":"Department of Pharmacology, St. Marianna University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Takenoshita-Nakaya","sequence":"additional","affiliation":[{"name":"Showa University Clinical Research Institute for Clinical Pharmacology and Therapeutics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Takeba","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, St. Marianna University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Showa University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Oda","sequence":"additional","affiliation":[{"name":"Department of Pharmacogenomics, St. Marianna University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Institute of Animal Experimentation, St. Marianna University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Ohta","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, St. Marianna University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinjiro","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Division of Gastroenterological and General Surgery, St. Marianna University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehito","family":"Ohtsubo","sequence":"additional","affiliation":[{"name":"Division of Gastroenterological and General Surgery, St. Marianna University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Showa University Clinical Research Institute for Clinical Pharmacology and Therapeutics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Uchida","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Showa University School of Medicine"},{"name":"Showa University Clinical Research Institute for Clinical Pharmacology and Therapeutics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, St. Marianna University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Nebert DW, Russell DW. Clinical importance of the cytochromes P450. <i>Lancet<\/i>, <b>360<\/b>, 1155\u20131162 (2002).","DOI":"10.1016\/S0140-6736(02)11203-7"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Lechevrel M, Casson AG, Wolf CR, Hardie LJ, Flinterman MB, Montesano R, Wild CP. Characterization of cytochrome P450 expression in human oesophageal mucosa. <i>Carcinogenesis<\/i>, <b>20<\/b>, 243\u2013248 (1999).","DOI":"10.1093\/carcin\/20.2.243"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Yokose T, Doy M, Kakiki M, Horie T, Matsuzaki Y, Mukai K. Expression of cytochrome P450 3A4 in foveolar epithelium with intestinal metaplasia of the human stomach. <i>Jpn. J. Cancer Res.<\/i>, <b>89<\/b>, 1028\u20131032 (1998).","DOI":"10.1111\/j.1349-7006.1998.tb00492.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Paine MF, Hart HL, Ludington SS, Haining RL, Rettie AE, Zeldin DC. The human intestinal cytochrome P450 \u201cpie.\u201d <i>Drug Metab. Dispos.<\/i>, <b>34<\/b>, 880\u2013886 (2006).","DOI":"10.1124\/dmd.105.008672"},{"key":"5","unstructured":"5) Pinto LF, Moraes E, Albano RM, Silva MC, Godoy W, Glisovic T, Lang MA. Rat oesophageal cytochrome P450 (CYP) monooxygenase system: comparison to the liver and relevance in <i>N<\/i>-nitrosodiethylamine carcinogenesis. <i>Carcinogenesis<\/i>, <b>22<\/b>, 1877\u20131883 (2001)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Vences-Mej\u00eda A, Caballero-Ortega H, Dorado-Gonz\u00e1lez V, Gamboa-Dom\u00ednguez A, G\u00f3mez-Ruiz C, Camacho-Carranza R, Espinosa-Aguirre JJ. Cytochrome P450 expression in rat gastric epithelium with intestinal metaplasia induced by high dietary NaCl levels. <i>Environ. Toxicol. Pharmacol.<\/i>, <b>20<\/b>, 57\u201364 (2005).","DOI":"10.1016\/j.etap.2004.10.010"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Paine MF, Shen DD, Kunze KL, Perkins JD, Marsh CL, McVicar JP, Barr DM, Gillies BS, Thummel KE. First-pass metabolism of midazolam by the human intestine. <i>Clin. Pharmacol. Ther.<\/i>, <b>60<\/b>, 14\u201324 (1996).","DOI":"10.1016\/S0009-9236(96)90162-9"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Wang MZ, Wu JQ, Bridges AS, Zeldin DC, Kornbluth S, Tidwell RR, Hall JE, Paine MF. Human enteric microsomal CYP4F enzymes <i>O<\/i>-demethylate the antiparasitic prodrug pafuramidine. <i>Drug Metab. Dispos.<\/i>, <b>35<\/b>, 2067\u20132075 (2007).","DOI":"10.1124\/dmd.107.016428"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Samer CF, Lorenzini KI, Rollason V, Daali Y, Desmeules JA. Applications of CYP450 testing in the clinical setting. <i>Mol. Diagn. Ther.<\/i>, <b>17<\/b>, 165\u2013184 (2013).","DOI":"10.1007\/s40291-013-0028-5"},{"key":"10","unstructured":"10) The Human Cytochrome P450 (<i>CYP<\/i>) Allele Nomenclature Database.: \u2039www.cypalleles.ki.se\/\u203a, cited 1 February, 2016."},{"key":"11","unstructured":"11) Ingelman-Sundberg M, Sim SC, Gomez A, Rodriguez-Antona C. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. <i>Pharmacol. Ther.<\/i>, <b>116<\/b>, 496\u2013526 (2007)."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Ingelman-Sundberg M. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. <i>Pharmacogenomics J.<\/i>, <b>5<\/b>, 6\u201313 (2005).","DOI":"10.1038\/sj.tpj.6500285"},{"key":"13","unstructured":"13) Kirchheiner J, Nickchen K, Bauer M, Wong ML, Licinio J, Roots I, Brockm\u00f6ller J. Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response. <i>Mol. Psychiatry<\/i>, <b>9<\/b>, 442\u2013473 (2004)."},{"key":"14","unstructured":"14) Nishida Y, Fukuda T, Yamamoto I, Azuma J. CYP2D6 genotypes in a Japanese population: low frequencies of CYP2D6 gene duplication but high frequency of CYP2D6*10. <i>Pharmacogenetics<\/i>, <b>10<\/b>, 567\u2013570 (2000)."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Kubota T, Yamaura Y, Ohkawa N, Hara H, Chiba K. Frequencies of CYP2D6 mutant alleles in a normal Japanese population and metabolic activity of dextromethorphan <i>O<\/i>-demethylation in different CYP2D6 genotypes. <i>Br. J. Clin. Pharmacol.<\/i>, <b>50<\/b>, 31\u201334 (2000).","DOI":"10.1046\/j.1365-2125.2000.00209.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Taguchi M, Nozawa T, Kameyama T, Inoue H, Takesono C, Mizukami A, Hashimoto Y. Effect of CYP2D6*10 on pharmacokinetic variability of routinely administered metoprolol in middle-aged and elderly Japanese patients. <i>Eur. J. Clin. Pharmacol.<\/i>, <b>59<\/b>, 385\u2013388 (2003).","DOI":"10.1007\/s00228-003-0638-7"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Yue QY, Zhong ZH, Tybring G, Dal\u00e9n P, Dahl ML, Bertilsson L, Sj\u00f6qvist F. Pharmacokinetics of nortriptyline and its 10-hydroxy metabolite in Chinese subjects of different CYP2D6 genotypes. <i>Clin. Pharmacol. Ther.<\/i>, <b>64<\/b>, 384\u2013390 (1998).","DOI":"10.1016\/S0009-9236(98)90069-8"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Hayashi M, Matsumoto N, Takenoshita-Nakaya S, Takeba Y, Watanabe M, Kumai T, Takagi M, Tanaka M, Otsubo T, Kobayashi S. Individual metabolic capacity evaluation of cytochrome P450 2C19 by protein and activity in the small intestinal mucosa of Japanese pancreatoduodenectomy patients. <i>Biol. Pharm. Bull.<\/i>, <b>34<\/b>, 71\u201376 (2011).","DOI":"10.1248\/bpb.34.71"},{"key":"19","unstructured":"19) Kimura S, Umeno M, Skoda RC, Meyer UA, Gonzalez FJ. The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene. <i>Am. J. Hum. Genet.<\/i>, <b>45<\/b>, 889\u2013904 (1989)."},{"key":"20","unstructured":"20) Johansson I, Oscarson M, Yue QY, Bertilsson L, Sj\u00f6qvist F, Ingelman-Sundberg M. Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation. <i>Mol. Pharmacol.<\/i>, <b>46<\/b>, 452\u2013459 (1994)."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Nakamura K, Goto F, Ray WA, McAllister CB, Jacqz E, Wilkinson GR, Branch RA. Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations. <i>Clin. Pharmacol. Ther.<\/i>, <b>38<\/b>, 402\u2013408 (1985).","DOI":"10.1038\/clpt.1985.194"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Ishizaki T, Eichelbaum M, Horai Y, Hashimoto K, Chiba K, Dengler HJ. Evidence for polymorphic oxidation of sparteine in Japanese subjects. <i>Br. J. Clin. Pharmacol.<\/i>, <b>23<\/b>, 482\u2013485 (1987).","DOI":"10.1111\/j.1365-2125.1987.tb03080.x"},{"key":"23","unstructured":"23) Horai Y, Nakano M, Ishizaki T, Ishikawa K, Zhou HH, Zhou BI, Liao CL, Zhang LM. Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese <i>versus<\/i> mainland Chinese. <i>Clin. Pharmacol. Ther.<\/i>, <b>46<\/b>, 198\u2013207 (1989)."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Watanabe M, Tateishi T, Tanaka M, Kumai T, Kobayashi S. Role of CYP3A in bromperidol metabolism in rat <i>in vitro<\/i> and <i>in vivo.<\/i> <i>Xenobiotica<\/i>, <b>29<\/b>, 839\u2013846 (1999).","DOI":"10.1080\/004982599238281"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Nishimura Y, Kurata N, Sakurai E, Yasuhara H. Inhibitory effect of antituberculosis drugs on human cytochrome P450-mediated activities. <i>J. Pharmacol. Sci.<\/i>, <b>96<\/b>, 293\u2013300 (2004).","DOI":"10.1254\/jphs.FP0040296"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Thelen K, Dressman JB. Cytochrome P450-mediated metabolism in the human gut wall. <i>J. Pharm. Pharmacol.<\/i>, <b>61<\/b>, 541\u2013558 (2009).","DOI":"10.1211\/jpp.61.05.0002"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Zhang QY, Dunbar D, Ostrowska A, Zeisloft S, Yang J, Kaminsky LS. Characterization of human small intestinal cytochromes P-450. <i>Drug Metab. Dispos.<\/i>, <b>27<\/b>, 804\u2013809 (1999).","DOI":"10.1016\/S0090-9556(24)15229-4"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Maximov PY, McDaniel RE, Fernandes DJ, Korostyshevskiy VR, Bhatta P, M\u00fcrdter TE, Flockhart DA, Jordan VC. Simulation with cells <i>in vitro<\/i> of tamoxifen treatment in premenopausal breast cancer patients with different CYP2D6 genotypes. <i>Br. J. Pharmacol.<\/i>, <b>171<\/b>, 5624\u20135635 (2014).","DOI":"10.1111\/bph.12864"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Nakamura T, Sakaeda T, Ohmoto N, Tamura T, Aoyama N, Shirakawa T, Kamigaki T, Nakamura T, Kim KI, Kim SR, Kuroda Y, Matsuo M, Kasuga M, Okumura K. Real-time quantitative polymerase chain reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA levels in Caco-2 cell lines, human duodenal enterocytes, normal colorectal tissues, and colorectal adenocarcinomas. <i>Drug Metab. Dispos.<\/i>, <b>30<\/b>, 4\u20136 (2002).","DOI":"10.1124\/dmd.30.1.4"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Th\u00f6rn M, Finnstr\u00f6m N, Lundgren S, Rane A, L\u00f6\u00f6f L. Cytochromes P450 and MDR1 mRNA expression along the human gastrointestinal tract. <i>Br. J. Clin. Pharmacol.<\/i>, <b>60<\/b>, 54\u201360 (2005).","DOI":"10.1111\/j.1365-2125.2005.02389.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Sakuyama K, Sasaki T, Ujiie S, Obata K, Mizugaki M, Ishikawa M, Hiratsuka M. Functional characterization of 17 CYP2D6 allelic variants (CYP2D6.2, 10, 14A-B, 18, 27, 36, 39, 47\u201351, 53\u201355, and 57). <i>Drug Metab. Dispos.<\/i>, <b>36<\/b>, 2460\u20132467 (2008).","DOI":"10.1124\/dmd.108.023242"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Honda M, Nozawa T, Igarashi N, Inoue H, Arakawa R, Ogura Y, Okabe H, Taguchi M, Hashimoto Y. Effect of CYP2D6*10 on the pharmacokinetics of R- and S-carvedilol in healthy Japanese volunteers. <i>Biol. Pharm. Bull.<\/i>, <b>28<\/b>, 1476\u20131479 (2005).","DOI":"10.1248\/bpb.28.1476"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Senda C, Yamaura Y, Kobayashi K, Fujii H, Minami H, Sasaki Y, Igarashi T, Chiba K. Influence of the CYP2D6*10 allele on the metabolism of mexiletine by human liver microsomes. <i>Br. J. Clin. Pharmacol.<\/i>, <b>52<\/b>, 100\u2013103 (2001).","DOI":"10.1046\/j.0306-5251.2001.01411.x"},{"key":"34","unstructured":"34) Gaedigk A, Bradford LD, Alander SW, Leeder JS. CYP2D6*36 gene arrangements within the CYP2d6 locus: association of CYP2D6*36 with poor metabolizer status. <i>Drug Metab. Dispos.<\/i>, <b>34<\/b>, 563\u2013569 (2006)."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Toda T, Ohi K, Kudo T, Yoshida T, Ikarashi N, Ito K, Sugiyama K. Ciprofloxacin suppresses Cyp3a in mouse liver by reducing lithocholic acid-producing intestinal flora. <i>Drug Metab. Pharmacokinet.<\/i>, <b>24<\/b>, 201\u2013208 (2009).","DOI":"10.2133\/dmpk.24.201"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Shimizudani T, Nagaoka K, Hanioka N, Yamano S, Narimatsu S. Comparative study of the oxidation of propranolol enantiomers in hepatic and small intestinal microsomes from cynomolgus and marmoset monkeys. <i>Chem. Biol. Interact.<\/i>, <b>183<\/b>, 67\u201378 (2010).","DOI":"10.1016\/j.cbi.2009.10.007"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Goodwin B, Hodgson E, D\u2019Costa DJ, Robertson GR, Liddle C. Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptor. <i>Mol. Pharmacol.<\/i>, <b>62<\/b>, 359\u2013365 (2002).","DOI":"10.1124\/mol.62.2.359"},{"key":"38","unstructured":"38) Kim SM, Acharya P, Engel JC, Correia MA. Liver cytochrome P450 3A ubiquitination <i>in vivo<\/i> by gp78\/autocrine motility factor receptor and C terminus of Hsp70-interacting protein (CHIP) E3 ubiquitin ligases: physiological and pharmacological relevance. <i>J. Biol. Chem.<\/i>, <b>285<\/b>, 35866\u201335877 (2010)."}],"container-title":["Biological &amp; Pharmaceutical Bulletin","Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/40\/9\/40_b16-00370\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T15:10:49Z","timestamp":1750345849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/40\/9\/40_b16-00370\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b16-00370","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"type":"print","value":"0918-6158"},{"type":"electronic","value":"1347-5215"}],"subject":[],"published":{"date-parts":[[2017]]}}}